Gritstone bio, Inc.
GRTSDelisted Mar 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001656634
Gritstone bio, Inc. was delisted on Mar 5, 2025; its insiders filed their last Form 4 on Apr 8, 2025; 56 institutions reported holding it in 13F filings for Q3 2024, worth $20.7M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Gritstone bio, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 117
- +2 vs. Q4 2021
- Shares held
- 40.0M
- −9.15M (−18.6%) vs. Q4 2021
- Total value
- $164.9M
- −$465.1M (−73.8%) vs. Q4 2021
- New holders
- 27
- 38 more added
- Sold out
- 25
- 35 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GRTS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 6 | $773 |
| Q3 2024 | 56 | $20.7M |
| Q2 2024 | 79 | $24.2M |
| Q1 2024 | 85 | $120.4M |
| Q4 2023 | 88 | $85.9M |
| Q3 2023 | 89 | $83.6M |
| Q2 2023 | 88 | $99.5M |
| Q1 2023 | 91 | $128.6M |
| Q4 2022 | 91 | $152.1M |
| Q3 2022 | 79 | $86.0M |
| Q2 2022 | 87 | $85.1M |
| Q1 2022 | 117 | $164.9M |
| Q4 2021 | 115 | $630.0M |
| Q3 2021 | 92 | $458.4M |
| Q2 2021 | 102 | $318.2M |
| Q1 2021 | 99 | $321.1M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Gritstone bio, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Goldman Sachs Group Inc | 289,897 | $1.19M | 0.00% | −151,864−34.4% | Reduced |
| Marshall Wace, LLP | 314,383 | $1.29M | 0.00% | +314,383 | New |
| Northern Trust Corp | 396,347 | $1.63M | 0.00% | −12,559−3.1% | Reduced |
| Avidity Partners Management LP | 560,000 | $2.31M | 0.05% | −3,810,000−87.2% | Reduced |
| Millennium Management LLC | 602,544 | $2.48M | 0.00% | +602,544 | New |
| Citadel Advisors LLC | 639,496 | $2.63M | 0.00% | +292,415+84.2% | Added |
| Artal Group S.A. | 750,000 | $3.09M | 0.13% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 760,986 | $3.47M | 0.00% | −218,357−22.3% | Reduced |
| Geode Capital Management, LLC | 863,550 | $3.56M | 0.00% | −4,178−0.5% | Reduced |
| State Street Corp | 969,982 | $4.00M | 0.00% | −2,703,797−73.6% | Reduced |
| Palo Alto Investors LP | 2,330,504 | $9.60M | 0.74% | −25,778−1.1% | Reduced |
| Vanguard Group Inc | 2,734,707 | $11.3M | 0.00% | +23,437+0.9% | Added |
| Deep Track Capital, LP | 2,985,729 | $12.3M | 0.79% | +1,213,928+68.5% | Added |
| Versant Venture Management, LLC | 3,561,150 | $14.7M | 14.65% | 00.0% | Unchanged |
| BlackRock Inc. | 3,893,393 | $16.0M | 0.00% | +101,960+2.7% | Added |
| Frazier Life Sciences Management, L.P. | 5,237,348 | $21.6M | 1.84% | +5,237,348 | New |
| Redmile Group, LLC | 6,871,738 | $28.3M | 0.88% | +3,442,567+100.4% | Added |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −6,012,232−100.0% | Sold out |
| Frazier Management LLC | 0 | $0 | 0.00% | −4,667,242−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −447,611−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −170,125−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −130,622−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −97,393−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −95,000−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −54,700−100.0% | Sold out |
| Putnam Investments LLC | 0 | $0 | 0.00% | −47,440−100.0% | Sold out |
| Triumph Capital Management | 0 | $0 | 0.00% | −32,000−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −30,601−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −15,799−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −15,691−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −13,797−100.0% | Sold out |
| Alta Wealth Advisors LLC | 0 | $0 | 0.00% | −12,371−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −10,669−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −10,414−100.0% | Sold out |
| Hershey Trust Co | 0 | $0 | 0.00% | −8,791−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −7,144−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −1,850−100.0% | Sold out |
| First Quadrant L P | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −1,245−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −204−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −100−100.0% | Sold out |